Immuneering Corporation Amortization of Intangible Assets
Immuneering Corporation (IMRX) reported Amortization of Intangible Assets of $7.32 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-05
- Immuneering Corporation amortization of intangible assets for the quarter ending 2026-06-30 was $7.32K, a 0.00% change year-over-year.
- Immuneering Corporation amortization of intangible assets for the quarter ending 2026-03-31 was $7.32K, a 0.00% change year-over-year.
- Immuneering Corporation amortization of intangible assets for the quarter ending 2025-12-31 was $7.32K, a 0.00% change year-over-year.
- Immuneering Corporation amortization of intangible assets for the quarter ending 2025-09-30 was $7.32K, a 0.00% change year-over-year.
- Immuneering Corporation amortization of intangible assets for fiscal 2025 was $29.27K, a 0.00% change from fiscal 2024.
- Immuneering Corporation amortization of intangible assets for fiscal 2024 was $29.27K, a 0.00% change from fiscal 2023.
- Immuneering Corporation amortization of intangible assets for fiscal 2023 was $29.27K, a 2.62% decline from fiscal 2022.
- Immuneering Corporation amortization of intangible assets for fiscal 2022 was $30.05K.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.32K 10-Q · filed 2026-08-05 | $14.63K 10-Q · filed 2026-08-05 | $21.95K derived: sum of 3 quarters · filed 2026-08-05 | $29.27K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $7.32K 10-Q · filed 2026-05-15 | $14.63K derived: sum of 2 quarters · filed 2026-05-15 | $21.95K derived: sum of 3 quarters · filed 2026-05-15 | $29.27K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $7.32K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $14.63K derived: sum of 2 quarters · filed 2026-03-06 | $21.95K derived: sum of 3 quarters · filed 2026-08-05 | $29.27K 10-K · filed 2026-03-06 |
| 2025-09-30 | $7.32K 10-Q · filed 2025-11-12 | $14.63K derived: sum of 2 quarters · filed 2026-08-05 | $21.95K 10-Q · filed 2025-11-12 | $29.27K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $7.32K 10-Q · filed 2026-08-05 | $14.63K 10-Q · filed 2026-08-05 | $21.95K derived: sum of 3 quarters · filed 2026-08-05 | $29.27K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $7.32K 10-Q · filed 2026-05-15 | $14.63K derived: sum of 2 quarters · filed 2026-05-15 | $21.95K derived: sum of 3 quarters · filed 2026-05-15 | $29.27K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $7.32K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $14.63K derived: sum of 2 quarters · filed 2026-03-06 | $21.95K derived: sum of 3 quarters · filed 2026-03-06 | $29.27K 10-K · filed 2026-03-06 |
| 2024-09-30 | $7.32K 10-Q · filed 2025-11-12 | $14.63K derived: sum of 2 quarters · filed 2025-11-12 | $21.95K 10-Q · filed 2025-11-12 | $29.27K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $7.32K 10-Q · filed 2025-08-13 | $14.63K 10-Q · filed 2025-08-13 | $21.95K derived: sum of 3 quarters · filed 2025-08-13 | $29.27K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $7.32K 10-Q · filed 2025-05-05 | $14.63K derived: sum of 2 quarters · filed 2025-05-05 | $21.95K derived: sum of 3 quarters · filed 2025-05-05 | $29.27K derived: sum of 4 quarters · filed 2025-05-05 |
| 2023-12-31 | $7.32K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $14.63K derived: sum of 2 quarters · filed 2025-03-20 | $21.95K derived: sum of 3 quarters · filed 2025-03-20 | $29.27K 10-K · filed 2025-03-20 |
| 2023-09-30 | $7.32K 10-Q · filed 2024-11-13 | $14.63K derived: sum of 2 quarters · filed 2024-11-13 | $21.95K 10-Q · filed 2024-11-13 | $29.27K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $7.32K 10-Q · filed 2024-08-06 | $14.63K 10-Q · filed 2024-08-06 | $21.95K derived: sum of 3 quarters · filed 2024-08-06 | $29.27K derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $7.32K 10-Q · filed 2024-05-07 | $14.63K derived: sum of 2 quarters · filed 2024-05-07 | $21.95K derived: sum of 3 quarters · filed 2024-05-07 | $29.27K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $7.32K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $14.63K derived: sum of 2 quarters · filed 2024-03-01 | $21.95K derived: sum of 3 quarters · filed 2024-03-01 | $30.05K 10-K · filed 2024-03-01 |
| 2022-09-30 | $7.32K 10-Q · filed 2023-11-09 | $14.63K derived: sum of 2 quarters · filed 2023-11-09 | $22.74K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $7.32K 10-Q · filed 2023-08-03 | $15.42K 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | $8.10K 10-Q · filed 2023-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |